Up-Regulated Expression of Matrix Metalloproteinases in Endothelial Cells Mediates Platelet Microvesicle-Induced Angiogenesis (original) (raw)
Article navigation
Research Articles| April 27 2017
aDepartment of Cardiology, Southwest Hospital, Third Military Medical University, Chongqing, China
Search for other works by this author on:
aDepartment of Cardiology, Southwest Hospital, Third Military Medical University, Chongqing, China
Search for other works by this author on:
bDepartment of Occupational Health, Third Military Medical University, Chongqing, China
Search for other works by this author on:
aDepartment of Cardiology, Southwest Hospital, Third Military Medical University, Chongqing, China
Search for other works by this author on:
aDepartment of Cardiology, Southwest Hospital, Third Military Medical University, Chongqing, China
Search for other works by this author on:
aDepartment of Cardiology, Southwest Hospital, Third Military Medical University, Chongqing, China
Search for other works by this author on:
bDepartment of Occupational Health, Third Military Medical University, Chongqing, China
Search for other works by this author on:
bDepartment of Occupational Health, Third Military Medical University, Chongqing, China
Search for other works by this author on:
aDepartment of Cardiology, Southwest Hospital, Third Military Medical University, Chongqing, China
Search for other works by this author on:
Cellular Physiology and Biochemistry (2017) 41 (6): 2319–2332.
- Split-Screen
- Views Icon Views Open Menu
- Download Icon Download Open Menu
- Tools Icon Tools Open Menu
- Search Site
Abstract
Background/Aims: Platelet microvesicles (PMVs) contribute to angiogenesis and vasculogenesis, but the mechanisms underlying these contributions have not been fully elucidated. In the present study, we investigated whether PMVs regulate the angiogenic properties of endothelial cells (ECs) via mechanisms extending beyond the transport of angiogenic regulators from platelets. Methods: In vitro Matrigel tube formation assay and in vivo Matrigel plug assay were used to evaluate the pro-angiogenic activity of PMVs. The effects of PMVs on the migration of human umbilical vein endothelial cells (HUVECs) were detected by transwell assay and wound-healing assay. Real-time PCR and western blot were conducted to examine mRNA and protein expression of pro-angiogenic factors in HUVECs. Matrix metalloproteinase (MMP) activity was assayed by gelatin zymography. Moreover, the effects of specific MMP inhibitors were tested. Results: PMVs promoted HUVEC capillary-like network formation in a dose-dependent manner. Meanwhile, PMVs dose-dependently facilitated HUVEC migration. Levels of MMP-2 and MMP-9 expression and activity were up-regulated in HUVECs stimulated with PMVs. Inhibition of MMPs decreased their pro-angiogenic and pro-migratory effects on HUVECs. Moreover, we confirmed the pro-angiogenic activity of PMVs in vivo in mice with subcutaneous implantation of Matrigel, and demonstrated that blockade of MMPs attenuated PMV-induced angiogenesis. Conclusion: The findings of our study indicate that PMVs promote angiogenesis by up-regulating MMP expression in ECs via mechanism extending beyond the direct delivery of angiogenic factors.
This content is only available via PDF.
© 2017 The Author(s). Published by S. Karger AG, Basel
2017
Open Access License / Drug Dosage / Disclaimer
This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND). Usage and distribution for commercial purposes as well as any distribution of modified material requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.